In response to the Martin Shkreli-style PR disaster, the company announced Thursday it has devised a supposed solution to the prohibitively high costs of the essential medicine. According to a statement from the corporation, the company plans to “further enhance access to EpiPen” by establishing a discount card and patient assistant system.
The post Why Mylan’s Alleged Solution To Its EpiPen Price-Gouging Scandal Is A Scam appeared first on The National Memo.